@jfais20 PD-1 / PD-L1 are tent-pole drugs for $MRK (Keytruda) and $BMY (Opdivo) with huge sales forces, advertising budget sand pipelines with other checkpoint inhibitors combo besides CTLA-4.   No way $AGEN can muscle into this market even with superior ORRs.